NCT02777346

Brief Summary

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization. Outcomes are:

  1. 1.infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)
  2. 2.scar appearance at a 6-months follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
550

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 19, 2016

Completed
8.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 6, 2025

Completed
Last Updated

July 4, 2025

Status Verified

July 1, 2025

Enrollment Period

8.8 years

First QC Date

May 17, 2016

Last Update Submit

July 1, 2025

Conditions

Keywords

WOUNDS, PENETRATINGCHILD, PRESCHOOLCHILDINFANTADOLESCENTSUTURESPOLYGLACTIN 910POLYPROPYLENES

Outcome Measures

Primary Outcomes (1)

  • Short-term infection risk

    Scars classified as "no evidence of infection", "signs of inflammation" and "signs of active infection"

    4 to 21 days

Secondary Outcomes (1)

  • Scar appearance

    6 months

Study Arms (2)

Absorbable

EXPERIMENTAL

Suture material: Polyglactin 910 thread (Vicryl Rapide®, Ethicon Inc).

Device: Absorbable

Non Absorbable

ACTIVE COMPARATOR

Suture material: Polypropylene thread (Prolene®, Ethicon Inc).

Device: Non absorbable

Interventions

Wound suture by a resident physician. Two follow-up appointments (first at 4 to 21 days after the suture, according to the sutured site as defined by protocol, second at 6 months) Standardized photography of the wound before the suture and at the two subsequent follow-ups. Evaluation of the scar with a standardised form by a specialised nurse under medical supervision at the first follow-up and by a panel of investigators at 6 months using the pictures taken at the follow-up appointments.

Absorbable

Wound suture by a resident physician. Two follow-up appointments (first at 4 to 21 days after the suture, according to the sutured site as defined by protocol, second at 6 months) Standardized photography of the wound before the suture and at the two subsequent follow-ups. Evaluation of the scar with a standardised form by a specialised nurse under medical supervision at the first follow-up and by a panel of investigators at 6 months using the pictures taken at the follow-up appointments.

Non Absorbable

Eligibility Criteria

Age1 Day - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patient younger than 16 years of age with a wound requiring suture

You may not qualify if:

  • Deep wounds with lesions of subcutaneous structures (tendons, nerves, etc.)
  • Wounds with tissue loss
  • Diabetic patients or patients treated with drugs potentially compromising cicatrization (e.g. steroids, immunosuppressors, etc.)
  • Wounds caused by animal or human bites
  • Sutures not performed in the emergency room
  • Heavily soiled wounds

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geneva University Hospital

Geneva, Canton of Geneva, 1205, Switzerland

Location

MeSH Terms

Conditions

Wounds and InjuriesWounds, Penetrating

Study Officials

  • Giorgio La Scala, MD PD

    University Hospital, Geneva

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PD, MD; Attending Surgeon

Study Record Dates

First Submitted

May 17, 2016

First Posted

May 19, 2016

Study Start

May 1, 2016

Primary Completion

February 6, 2025

Study Completion

February 6, 2025

Last Updated

July 4, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations